Fount of Information

Atlas Antibodies社 The Human Protein Atlas -Spatial proteomics in health and disease

Atlas Antibodies logo.png
The Human Protein Atlas -Spatial proteomics in health and disease

Tue, Jun 14, 2022 3:00 PM - 4:00 PM JST

The spatial distribution of proteins determines the morphology and function of tissues, cells, and organelles, and knowledge of this spatial distribution is therefore essential to understand the healthy and diseased human body. The Human Protein Atlas (HPA) project is a large-scale initiative aiming at mapping the entire human proteome using antibody-based proteomics and integration of various other omics technologies. The publicly available knowledge resource www.proteinatlas.org has grown into one of the world’s most visited biological databases and contains information on different aspects of the human proteome. Recently, a large effort was put into generation of expression profiles in single cell types, with the possibility to explore mRNA and protein expression in different single cell types across all major human organs. The HPA constitutes an important resource for spatial proteomics, precision medicine efforts and further understanding of human biology, and the publicly available datasets hold much promise for integration with other emerging efforts both at transcriptomic and proteomic level. cecilia_lindskog_small.jpg

In this webinar, Dr. Cecilia Lindskog discusses how spatial proteomics can contribute to further understanding of human biology. You will learn:

• How the HPA resource can be used to study mRNA and protein expression profiles across tissues, cells, and organelles

• About the importance of stringent antibody validation for reliable protein detection

• How integration of data across platforms and technologies allows for characterizing the human building blocks at higher resolution

Link to the recorded webinar on a Vimeo platform

https://vimeo.com/720149131/78942a0f90

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。